CARBIDOPA, LEVODOPA AND ENTACAPONE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
16571-689 -
Package NDC
16571-689-01 -
Application number
ANDA213212 -
SPL ID
4d1e7e53-059c-4a41-86b0-66d20ce660d0 -
SPL set ID
2f8e82d7-6baf-456a-b8c3-4fda6e317902 -
UNII
4975G9NM6T -
UNII
MNX7R8C5VO -
UNII
46627O600J -
RxCUI
403850 -
RxCUI
403851 -
RxCUI
403852 -
RxCUI
730988 -
RxCUI
810083 -
RxCUI
810090
What the source publishes
- Labeler
- Rising Pharma Holdings, Inc.
- Active ingredients
- CARBIDOPA, LEVODOPA AND ENTACAPONE
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "CARBIDOPA, LEVODOPA AND ENTACAPONE",
"splId": "4d1e7e53-059c-4a41-86b0-66d20ce660d0",
"labels": [
{
"setId": "2f8e82d7-6baf-456a-b8c3-4fda6e317902",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2f8e82d7-6baf-456a-b8c3-4fda6e317902",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2f8e82d7-6baf-456a-b8c3-4fda6e317902"
}
],
"routes": [
"ORAL"
],
"labeler": "Rising Pharma Holdings, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET, FILM COATED in 1 BOTTLE (16571-689-01)",
"package_ndc": "16571-689-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20210805"
}
],
"productId": "16571-689_4d1e7e53-059c-4a41-86b0-66d20ce660d0",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "16571-689",
"deaSchedule": null,
"genericName": "CARBIDOPA, LEVODOPA AND ENTACAPONE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CARBIDOPA",
"strength": "12.5 mg/1"
},
{
"name": "LEVODOPA",
"strength": "50 mg/1"
},
{
"name": "ENTACAPONE",
"strength": "200 mg/1"
}
],
"applicationNumber": "ANDA213212",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20210805",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175756",
"N0000175757",
"N0000175754",
"N0000175755",
"N0000193220",
"M0370111"
],
"upc": [
"0316571690015",
"0316571694013",
"0316571692019",
"0316571691012",
"0316571693016"
],
"unii": [
"4975G9NM6T",
"MNX7R8C5VO",
"46627O600J"
],
"rxcui": [
"403850",
"403851",
"403852",
"730988",
"810083",
"810090"
],
"spl_set_id": [
"2f8e82d7-6baf-456a-b8c3-4fda6e317902"
],
"pharm_class_cs": [
"Amino Acids, Aromatic [CS]"
],
"pharm_class_epc": [
"Catechol-O-Methyltransferase Inhibitor [EPC]",
"Aromatic Amino Acid Decarboxylation Inhibitor [EPC]",
"Aromatic Amino Acid [EPC]"
],
"pharm_class_moa": [
"Catechol O-Methyltransferase Inhibitors [MoA]",
"DOPA Decarboxylase Inhibitors [MoA]"
],
"manufacturer_name": [
"Rising Pharma Holdings, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:16571-689_4d1e7e53-059c-4a41-86b0-66d20ce660d0"